Description  Claims  Cited references 

EP1166785A1   [0006] 
EP0667345A   [0006] 
WO2013163279A   [0007]  [0129] 
WO2013163244A   [0007] 
WO2013163241A   [0007] 

Nature   [0004] 
N. Eng. J. Med.   [0004] 
Synthesis of 1-Benzyl-3-(5'-hydroxymethyl-2'-furyl)indazole Analogues as Novel Antiplatelet Agents   [0005] 
Selective Inhibition of Protease-activated Receptor 4-dependent Platelet Activation by YD-3   [0005] 
Synthesis and antiplatelet activity of ethyl 4-(1-benzyl-1H-indazol-3-yl)benzoate (YD-3) derivatives   [0005] 
Remington: The Science and Practice of Pharmacy   [0094] 
Medicine   [0120] 
N. Engl. J. Med.   [0120] 
JAMA   [0120] 
Remington: The Science and Practice of Pharmacy   [0121] 
ique pathway of thrombin-induced platelet aggregation mediated by glycoprotein Ib   [0131] 
Thrombin receptor antagonists   [0135] 
Nonpeptide factor Xa inhibitors: II. Antithrombotic evaluation in a rabbit model of electrically induced carotid artery thrombosis   [0144] 
The P2Y1 receptor antagonist MRS2500 prevents carotid artery thrombosis in cynomolgus monkeys   [0144] 
Greene's Protective Groups In Organic Synthesis   [0148]  [0161]